Division of International Collaboration International Collaborative Research Program: Strategic International Collaborative Research Program (SICORP)
Outline
| Key Fields | Other programs(1st) |
|---|---|
| R&D phase | Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Trials, Post Marketing, Clinical Research, None |
| Contact |
|
The aim of this program is to contribute solutions to challenges facing world today and to bolster Japan’s scientific and technological capabilities through collaboration with a broad range of countries．
This program provides support for international joint research projects on the basis of equal partnership in countries，regions，and fields of cooperation that have been designated as particularly important by the Ministry of Education，Culture，Sports，Science and Technology（MEXT）on the basis of intergovernmental agreements，in collaboration with funding agencies in the countries concerned．
Implementing Body
SICORP (Singapore)
- Research Area – "Biological and Molecular Determinants of Human Ageing"
- The aims are to: 1) strengthen research collaborations between Japan and Singapore within the field of ”Biological and Molecular Determinants of Human Ageing”; and 2) achieve world-class scientific results through the development and use of new and innovative technologies which can address the challenges facing the international community in the area of health research in both countries.
- Funding Agency of Singapore Side
- Agency for Science, Technology and Research (A*STAR)
- Duration: FY2017 - FY2021
| Project Title | Biological signatures of cardiovascular, musculoskeletal and cognitive ageing in the very old | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. Yasumichi Arai | Dr. Woon-Puay Koh |
| Affiliation | Keio University School of Medicine | Duke-NUS Medical School |
| Project Title | Effect of aging of the innate immune system on intracellular system network | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. Katsuhito Fujiu | Dr. Xiaomeng Wang |
| Affiliation | The University of Tokyo | Singapore Eye Research Institute (SERI) |
| Project Title | Targeting age-associated white matter lesions | |
|---|---|---|
| Country | Japan | Singapore |
| PI |
Dr. Masafumi Ihara |
Dr. Peter Tsun-Hon Wong |
| Affiliation | National Cerebral and Cardiovascular Center | National University of Singapore |
Research Area – "Cell Therapy - a focus on quality, efficacy and safety"- The aims are to: 1) strengthen research collaborations between Japan and Singapore within the field of ”Cell Therapy - a focus on quality, efficacy and safety” ; and 2) achieve world-class scientific results through the development and use of new and innovative technologies which can address the challenges facing the international community in the area of health research in both countries.
- Funding Agency of Singapore Side
- Agency for Science, Technology and Research (A*STAR)
- Duration: FY2019 - FY2022
| Project Title | Developing a safe and potentially efficacious piggyBac-based CAR-T cell strategy for virus-related cancers | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. Shoji Saito | Dr. Timothy Wai Ho Shuen |
| Affiliation | Department of Pediatric, Shinshu University | Division of Medical Oncology, National Cancer Centre Singapore |
| Project Title | Large-scale Preparation of Hair Follicle Germs using Hydrogel Printing | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. Tatsuto Kageyama | Dr. Michinao Hashimoto |
| Affiliation | Kanagawa Institute of Industrial Science and Technology (KISTEC) | Singapore University of Technology and Design |
| Project Title | Human stem cell-derived pancreatic beta cells for the treatment of diabetes | |
|---|---|---|
| Country | Japan | Singapore |
| PI |
Dr. Jun Shirakawa |
Dr. Adrian Kee Keong Teo |
| Affiliation | Department of Endocrinology and Metabolism, Yokohama City university | A*STAR/NUS Medicine, the Institute of Molecular and Cell Biology (IMCB) |
SICORP (Spain)
- Research Area – "Nanomedicine"
- The aims are to:
1) Strengthen research collaborations between Japan and Spain within the field of Nanomedicine;
2) Achieve world-class scientific results through the development and use of new and innovative
technologies which can address the challenges facing the international community in the area of
health research in both countries. - Funding Agency of Spain Side
- State Research Agency of Spain （AEI）
- Duration: FY2018 - FY2021
| Project Title | Development of phototherapeutic strategies for amyloid-related diseases enabled by a nanoscale view of amyloid photodamage (AMYLIGHT) | |
|---|---|---|
| Country | Japan | Spain |
| PI | Dr. Youhei Sohma | Dr. Cristina Flors |
| Affiliation | University of Tokyo | IMDEA Nanociencia |
| Project Title | Drug delivery targeting Brain CPT1: a novel nanomedicine-based approach to fight obesity and cancer (COnCorD) | |
|---|---|---|
| Country | Japan | Spain |
| PI | Dr. Sabina Quader | Dr. Rosalía Rodríguez-Rodríguez |
| Affiliation | Innovation Centre of Nanomedicine (iCONM) | Universidad Internacional de Cataluña |
| Project Title | Nano-scaffolding for neuronal migration and regeneration (Nano-ReBrain) | |
|---|---|---|
| Country | Japan | Spain |
| PI | Dr. Naoko Kaneko | Dr. Vicente Herranz-Pérez |
| Affiliation | Nagoya City University | Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED) |
SICORP (UK)
- Research Area – "Infectious Diseases"
- The overarching aim of the UK-Japan collaborative initiative in infectious diseases is to provide bi-lateral support to biomedical and health researchers in the UK and Japan that will allow them to forge lasting collaborations. This initative aims to strengthen existing links or foster new links that add value to research taking place in both countries. This is expected to be achieved by facilitating exchange and catalysing innovative synergy amongst collaborators and is particularly aimed at those who are in the early stages of their careers.
- Funding Agency of the UK Side
- The UK Medical Research Council（MRC）
- Duration: FY2019 - FY2022
| Project Title | Elucidation of cell-autonomous immunity and host defense against Toxoplasma gondii by interferon-inducible GTPases | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Masahiro Yamamoto | Dr. Eva-Maria Frickel |
| Affiliation | Research Institute for Microbial Diseases, Osaka University | The University of Birmingham |
| Project Title | Interferon stimulated defences that target Hepatitis B Virus (HBV) and Hepatitis D Virus (HDV) | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Koichi Watashi | Dr. Sam Wilson |
| Affiliation | National Institute of Infectious Diseases | MRC University of Glasgow Centre for Virus Research (CVR) |
| Project Title | Dynamic Imaging in Viral Encephalitis Defines Unique Roles for Chemoattractants | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Yoshishige Miyabe | Dr. Benedict Michael |
| Affiliation | Nippon Medical School | University of Liverpool |
| Project Title | The HDAC6/USP7 axis in enveloped RNA virus infection | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Yasuyuki Miyake | Dr. Yohei Yamauchi |
| Affiliation | Nagoya University Graduate School of Medicine | University of Bristol School of Cellular and Molecular Medicine |
| Project Title | Systematic analysis of persistence mechanisms by high-throughput bar-seq and single cell analyses | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Ai Muto-Fujita | Dr. Suzie Hingley-Wilson |
| Affiliation | Nara Institute of Science and Technology | University of Surrey |
| Project Title | A cross-sectional approach to identification & interrogation of adaptive & functional mutations affecting CCHFV replication & pathogenicity in humans | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Kouichi Morita | Dr. David Allen |
| Affiliation | Institute of Tropical Medicine, Nagasaki University | London School of Hygiene and Tropical Medicine (LSHTM) |
| Project Title | Study of the T cell Response During Cryptococcal Meningitis Using New Tools | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Kazuyoshi Kawakami | Dr. Rebecca Drummond |
| Affiliation | Tohoku University Graduate School of Medicine | University of Birmingham |
| Project Title | The human T-cell leukaemia virus HTLV-1: transcriptional heterogeneity at the single-cell level | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. Yorifumi Sato | Dr. Charles Bangham |
| Affiliation | Kumamoto University | Imperial College |
Results Report
Management and Evaluation Framework
PS（Program Supervisor）
Toshio Suda, M.D., Ph.D., Director and Professor, International Research Center for Medical Sciences, Kumamoto University / Professor, Cancer Science Institute, National University of SingaporePO（Program Officer）
SICORP (Singapore)
Research Area - "Biological and Molecular Determinants of Human Ageing"Masahiro Akishita, M.D., Ph.D., Professor, Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo / Vice Director, Institute of Gerontology, The University of Tokyo / Vice Director, The University of Tokyo Hospital
Research Area - "Cell Therapy - a fucus on quality, efficacy and safety"Hiroshi Shiku, M.D., Ph.D., Professor, Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine
SICORP (Spain)
Hiroshi Handa, M.D., Ph.D., Professor, Department of Nanoparticle Translational Research, Tokyo Medical University
SICORP (UK)
Hironori Sato, M.D., Ph.D., Chief, Pathogen Genomics Center, The National Institute of Infectious Diseases
SICORP (Germany)
Tadashi Isa, M.D., Ph.D., Professor of Neuroscience, Graduate School of Medicine, Kyoto University / Vice Director, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University / Vice Dean, Graduate School of Medicine, Kyoto University / Chair, Human Brain Research Centre, Graduate School of Medicine, Kyoto University
Brochure
Last updated 2020.4.30